Announcements

27 February 2026
Vaccines | Editor’s Choice Papers in 2024 (III)

1. “Hybrid Immunity against SARS-CoV-2 Variants: A Narrative Review of the Literature”
by Panagiota Tsagkli, Maria Geropeppa, Ioanna Papadatou and Vana Spoulou
Vaccines 2024, 12(9), 1051; https://doi.org/10.3390/vaccines12091051
Available online: https://www.mdpi.com/2076-393X/12/9/1051

2. “Lessons from Recent Measles Post-Campaign Coverage Surveys Worldwide”
by M. Carolina Danovaro-Holliday, Mitsuki Koh, Claudia Steulet, Dale A. Rhoda and Mary Kay Trimner
Vaccines 2024, 12(11), 1257; https://doi.org/10.3390/vaccines12111257
Available online: https://www.mdpi.com/2076-393X/12/11/1257

3. “Childhood Mandatory Vaccinations: Current Situation in European Countries and Changes Occurred from 2014 to 2024”
by Sara Farina, Alessandra Maio, Maria Rosaria Gualano, Walter Ricciardi and Leonardo Villani
Vaccines 2024, 12(11), 1296; https://doi.org/10.3390/vaccines12111296
Available online: https://www.mdpi.com/2076-393X/12/11/1296

4. “Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans”
by Alina Tscherne, Georgia Kalodimou, Alexandra Kupke, Cornelius Rohde, Astrid Freudenstein, Sylvia Jany, Satendra Kumar, Gerd Sutter, Verena Krähling, Stephan Becker and Asisa Volz
Vaccines 2024, 12(12), 1316; https://doi.org/10.3390/vaccines12121316
Available online: https://www.mdpi.com/2076-393X/12/12/1316

5. “The Strategic Advisory Group of Experts (SAGE) on Immunization—Past, Present and Future”
by Melanie Marti, Hanna Nohynek, Philippe Duclos, Katherine L. O’Brien and Joachim Hombach
Vaccines 2024, 12(12), 1402; https://doi.org/10.3390/vaccines12121402
Available online: https://www.mdpi.com/2076-393X/12/12/1402

6. “Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus”
by Philip Hicks, Tomaz B. Manzoni, Jonna B. Westover, Raegan J. Petch, Brianne Roper, Brian B. Gowen and Paul Bates
Vaccines 2024, 12(12), 1403; https://doi.org/10.3390/vaccines12121403
Available online: https://www.mdpi.com/2076-393X/12/12/1403

7. “Development Using Bioluminescence Imaging of a Recombinant Anguillid Herpesvirus 1 Vaccine Candidate Associated with Normal Replication In Vitro but Abortive Infection In Vivo”
by Haiyan Zhang, Arun Sridhar, Natacha Delrez, Bo He, Sophie Fourny, Yuan Gao, Owen Donohoe and Alain F. C. Vanderplasschen
Vaccines 2024, 12(12), 1423; https://doi.org/10.3390/vaccines12121423
Available online: https://www.mdpi.com/2076-393X/12/12/1423

8. “Immunoprophylaxis with MV140 Is Effective in the Reduction of Urinary Tract Infections—A Prospective Real-Life Study”
by Filipe Abadesso Lopes, Miguel Miranda, André Ye, Joana Rodrigues, Paulo Pé-Leve, José Palma Reis and Ricardo Pereira e Silva
Vaccines 2024, 12(12), 1426; https://doi.org/10.3390/vaccines12121426
Available online: https://www.mdpi.com/2076-393X/12/12/1426

9. “Durability of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2”
by Achilleas Livieratos, Lars Erik Schiro, Charalambos Gogos and Karolina Akinosoglou
Vaccines 2024, 12(12), 1444; https://doi.org/10.3390/vaccines12121444
Available online: https://www.mdpi.com/2076-393X/12/12/1444

10. “Transforming Aquaculture through Vaccination: A Review on Recent Developments and Milestones”
by Iosif Tammas, Konstantina Bitchava and Athanasios I. Gelasakis
Vaccines 2024, 12(7), 732; https://doi.org/10.3390/vaccines12070732
Available online: https://www.mdpi.com/2076-393X/12/7/732

11. “Implementation of mRNA–Lipid Nanoparticle Technology in Atlantic Salmon (Salmo salar)”
by Lars Ole Sti Dahl, Sjoerd Hak, Stine Braaen, Alicja Molska, Francesca Rodà, Jeremie Parot, Øystein Wessel, Johanna Hol Fosse, Håvard Bjørgen, Sven Even Borgos and Espen Rimstad
Vaccines 2024, 12(7), 788; https://doi.org/10.3390/vaccines12070788
Available online: https://www.mdpi.com/2076-393X/12/7/788

12. “The Problem with Delaying Measles Elimination”
by Natasha S. Crowcroft, Anna A. Minta, Shelly Bolotin, Tania Cernuschi, Archchun Ariyarajah, Sébastien Antoni, Mick N. Mulders, Anindya S. Bose and Patrick M. O’Connor
Vaccines 2024, 12(7), 813; https://doi.org/10.3390/vaccines12070813
Available online: https://www.mdpi.com/2076-393X/12/7/813

More News...
Back to TopTop